Cover Image

Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer

Rossella De Luca,1 Livio Blasi,2 Massimiliano Alù,2 Valerio Gristina,1 Giuseppe Cicero1 1Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy; 2Medical Oncology Unit, ARNAS Hospital Civico, Di Cristina, Benfratelli, Palermo, Italy...

Full description

Saved in:

Bibliographic Details
Main Authors:	De Luca R (Author), Blasi L (Author), Alù M (Author), Gristina V (Author), Cicero G (Author)
Format:	Book
Published:	Dove Medical Press, 2018-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
by: Lazzaro C, et al.
Published: (2013)

Pharmacoeconomic analysis of atezolizumab plus nab-paclitaxel in the treatment of the advanced or metastatic triple-negative breast cancer
by: A S Kolbin, et al.
Published: (2020)

Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective
by: Dranitsaris G, et al.
Published: (2015)

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life
by: Palumbo R, et al.
Published: (2015)

Clinical Characteristics and Risk Factors of Lung Injury Induced by Nab-Paclitaxel
by: Yoshioka K, et al.
Published: (2022)

A Case of Stress Cardiomyopathy With Nab-Paclitaxel Infusion
by: Harjinder Singh MD, et al.
Published: (2023)

Durable response to the combination of pembrolizumab and nab-paclitaxel in a metastatic extrahepatic cholangiocarcinoma: A case report and literature review
by: Sirui Tan, et al.
Published: (2022)

Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma
by: Nan Zhou, et al.
Published: (2023)

Safety of nab-paclitaxel following an allergic reaction to paclitaxel: A single institution retrospective study
by: Swapna Kochuveettil, et al.
Published: (2024)

Atezolizumab plus carboplatin and nab‐paclitaxel versus carboplatin and nab‐paclitaxel as treatments for Chinese, treatment‐naïve, stage IV, non‐squamous, non‐small‐cell lung cancer patients: A retrospective analysis
by: Yingkai Chen, et al.
Published: (2022)

Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy
by: Jingjing Zhang, et al.
Published: (2023)

Protocol of the IntenSify‐Trial: An open‐label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab‐paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy
by: Nicolas Hohmann, et al.
Published: (2023)

Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel
by: Anne Steins, et al.
Published: (2017)

Evaluation of the Clinical Outcome of Nab-paclitaxel on Multiple Primary Malignancies: A Systematic Review and Meta-analysis
by: Fatemeh Salehi Kahrizsangi, et al.
Published: (2022)

Complete response of refractory mycosis fungoides to treatment of pancreatic cancer with combination gemcitabine and nab-paclitaxel: A possible new regimen for the treatment of advanced cutaneous T-cell lymphoma
by: Michelle Pratt, MD, et al.
Published: (2020)

Case report: Idiopathic pulmonary fibrosis induced by nab-paclitaxel: A rare complication
by: Jiahui Shen, et al.
Published: (2023)

Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)
by: Peng Cao, et al.
Published: (2023)

Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel
by: Jessica D. Lang, et al.
Published: (2023)

Nab-paclitaxel-associated photosensitivity: report in a woman with non-small cell lung cancer and review of taxane-related photodermatoses
by: Bryce D. Beutler, et al.
Published: (2015)

Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer
by: Chen-Yu Wang, et al.
Published: (2024)

Physicochemical Stability of Nab-Paclitaxel (Pazenir) Infusion Dispersions in Original Glass Vials and EVA Infusion Bags
by: Helen Linxweiler, et al.
Published: (2024)

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
by: Gridelli C, et al.
Published: (2018)

The Last Laird of MacNab An Episode in the Settlement of MacNab Township, Upper Canada
by: Fraser, Alexander, 1860-1936 [Editor]

Metastatic Pancreatic Cancer: Where Are We?
by: Abraham Hernández-Blanquisett, et al.
Published: (2024)

Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors
by: Jimmy He, et al.
Published: (2022)

Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer
by: Chen Y, et al.
Published: (2020)

Dermatomal eruption as the first clinical manifestation of recurrent metastatic pancreatic cancer
by: Redina Bardhi, BS, et al.
Published: (2021)

Prognostic impact of adding bevacizumab to carboplatin and paclitaxel for recurrent, persistent, or metastatic cervical cancer
by: Masafumi Yasunaga, et al.
Published: (2022)

Antioxidant properties of Helichrysum pseudoplicatum Nab
by: Mohammad Ali Ebrahimzadeh, et al.
Published: (2015)

Impact of Ninjin'Yoeito on Fatigue in Patients Receiving Nab-Paclitaxel Plus Gemcitabine Therapy: A Prospective, Single-Arm, Phase II Open Label, Nonrandomized, Historically-Controlled Study
by: Ken-ichi Okada, MD, PhD, et al.
Published: (2020)

Cancer cell membrane-coated bacterial ghosts for highly efficient paclitaxel delivery against metastatic lung cancer
by: Dandan Ling, et al.
Published: (2024)

A case of metastatic basal cell carcinoma treated with carboplatin and paclitaxel
by: Chryssoula Papageorgiou, et al.
Published: (2023)

A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report
by: Luke Meredith, et al.
Published: (2023)

Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure-safety analyses in patients with metastatic pancreatic cancer
by: Karl Brendel, et al.
Published: (2021)

Excretion of the Polymyxin Derivative NAB739 in Murine Urine
by: Martti Vaara, et al.
Published: (2020)

Clinical trials and progress with paclitaxel in ovarian cancer
by: Sanjeev Kumar, et al.
Published: (2010)

Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis
by: Wang Y, et al.
Published: (2016)

Case report: Long-term partial response of apatinib plus paclitaxel as second-line therapy in a patient with metastatic gastric cancer
by: Shengya Fu, et al.
Published: (2022)

Clinical case use bevacizumab for patient with metastatic ovarian cancer
by: M. R. Oganyan, et al.
Published: (2014)

TAS-102 in metastatic colorectal cancer (mCRC): efficacy, tolerability, and quality of life in heavily pretreated elderly patients: a real-life study
by: Giuseppe Cicero, et al.
Published: (2020)